EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals

Hareesh Singam, Sherif Mossad iD

Genes · 2025

DOI: 10.3390/genes16091058 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2025. Verfasst von Hareesh Singam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Section of Transplant Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Azoles, Polymorphism, Genetic, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Azoles are the primary agents for antifungal activity in clinical medicine due to their broad-spectrum efficacy and favorable safety profiles compared to older agents. Triazoles, including fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, have varied pharmacokinetic and pharmacodynamic properties. This is due to various polymorphisms in hepatic enzymes, necessitating genotype-guided dosing and therapeutic drug monitoring (TDM) to optimize treatment outcomes. This review highlights the clinical relevance of pharmacogenomics in azole therapy, particularly the role of cytochrome P450 (CYP450) enzyme polymorphisms in influencing drug levels, efficacy, and toxicity. Understanding these genetic and metabolic factors is essential for personalized antifungal treatment strategies, improving patient safety and therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsAzolesPolymorphism, GeneticCytochrome P-450 Enzyme SystemMycosesHumansPharmacogeneticsTriazolesDrug Monitoring

Stichwörter der Autor:innen

CYP2C19cytochrome P450itraconazoleposaconazoletherapeutic drug monitoringvoriconazole

Substanzen

Antifungal AgentsAzolesCytochrome P-450 Enzyme SystemTriazoles

Autor:innen und Institutionen

  • Department of Infectious Diseases, Section of Transplant Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

ORCID-Profile: Sherif Mossad

Zitieren

APA

Singam, H., & Mossad, S. (2025). The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals. Genes. https://doi.org/10.3390/genes16091058

Vancouver

Singam H, Mossad S. The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals. Genes. 2025. doi:10.3390/genes16091058

BibTeX
@article{Singam2025,
  author = {Singam, Hareesh and Mossad, Sherif},
  title = {The Impact of Genetic Polymorphisms on the Clinical Efficacy of Azole Antifungals},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16091058}
}
Kostenlos starten →